Luminex Corp. Company Profile (NASDAQ:LMNX)

About Luminex Corp.

Luminex Corp. logoLuminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company's FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry. By using its xMAP technology, the end users are able to generate multiple simultaneous results per sample. The Company primarily serves the diagnostics, pharmaceutical and life sciences industries by marketing products, including its testing equipment and assays, to various types of testing laboratories. The Company's assay products are focused on three segments of the molecular diagnostic testing market: human genetics, personalized medicine and infectious disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Life Sciences Tools & Services
  • Exchange: NASDAQ
  • Symbol: LMNX
  • CUSIP: 55027E10
Key Metrics:
  • Previous Close: $22.55
  • 50 Day Moving Average: $21.68
  • 200 Day Moving Average: $20.71
  • 52-Week Range: $16.16 - $23.75
  • Trailing P/E Ratio: 23.54
  • Foreward P/E Ratio: 35.79
  • P/E Growth: 0.64
  • Market Cap: $982.01M
  • Outstanding Shares: 43,548,000
  • Beta: 0.45
Profitability:
  • Net Margins: 16.60%
  • Return on Equity: 13.65%
  • Return on Assets: 12.52%
Debt:
  • Current Ratio: 4.79%
  • Quick Ratio: 3.54%
Additional Links:
Companies Related to Luminex Corp.:

Analyst Ratings

Consensus Ratings for Luminex Corp. (NASDAQ:LMNX) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $21.75 (3.55% downside)

Analysts' Ratings History for Luminex Corp. (NASDAQ:LMNX)
Show:
DateFirmActionRatingPrice TargetDetails
8/18/2016JPMorgan Chase & Co.UpgradeUnderweight -> Neutral$18.00 -> $22.00View Rating Details
7/28/2016Jefferies GroupBoost Price TargetHold$21.00 -> $23.00View Rating Details
5/3/2016Piper Jaffray Cos.Reiterated RatingHold$19.00 -> $20.00View Rating Details
5/3/2016Leerink SwannReiterated RatingHold$22.00View Rating Details
2/2/2016William BlairReiterated RatingMarket PerformView Rating Details
8/4/2015WedbushUpgradeNeutral -> Outperform$19.00 -> $22.00View Rating Details
7/1/2015Cowen and CompanyBoost Price TargetMarket Perform$17.00 -> $18.00View Rating Details
10/28/2014StephensDowngradeOverweight -> Equal WeightView Rating Details
10/9/2014Citigroup Inc.Initiated CoverageNeutralView Rating Details
(Data available from 9/29/2014 forward)

Earnings

Earnings History for Luminex Corp. (NASDAQ:LMNX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/31/2016        
7/28/2016Q216$0.15$0.33$61.20 million$64.20 millionViewListenView Earnings Details
5/2/2016Q116$0.14$0.29$60.98 million$63.00 millionViewListenView Earnings Details
2/1/2016Q415$0.15$0.56$60.16 million$60.40 millionViewN/AView Earnings Details
11/2/2015Q315$0.11$0.22$57.24 million$60.60 millionViewListenView Earnings Details
8/3/2015Q215$0.11$0.27$57.01 million$58.90 millionViewListenView Earnings Details
5/4/2015Q115$0.12$0.23$56.50 million$57.70 millionViewListenView Earnings Details
2/2/2015Q414$0.12$0.19$58.31 million$58.10 millionViewListenView Earnings Details
10/27/2014Q314$0.10$0.27$56.60 million$56.68 millionViewListenView Earnings Details
7/28/2014Q214$0.10$0.20$55.90 million$55.50 millionViewListenView Earnings Details
4/28/2014Q114$0.12$0.24$55.31 million$56.60 millionViewListenView Earnings Details
2/3/2014Q413$0.07$0.21$56.63 million$55.20 millionViewListenView Earnings Details
11/4/2013Q313$0.11$0.02$54.67 million$50.80 millionViewListenView Earnings Details
7/29/2013Q2 2013$0.10$0.17$54.16 million$54.30 millionViewListenView Earnings Details
4/29/2013Q1 2013$0.08$0.19$51.94 million$53.20 millionViewListenView Earnings Details
2/4/2013Q4 2012$0.08$0.12$54.09 million$55.53 millionViewListenView Earnings Details
10/29/2012Q312$0.06$0.04$51.26 million$50.00 millionViewN/AView Earnings Details
7/30/2012$0.08$0.07ViewN/AView Earnings Details
4/30/2012$0.09$0.08ViewN/AView Earnings Details
2/6/2012$0.07$0.11ViewN/AView Earnings Details
11/1/2011$0.05$0.05ViewN/AView Earnings Details
8/8/2011$0.06$0.11ViewN/AView Earnings Details
5/9/2011$0.06$0.11ViewN/AView Earnings Details
2/7/2011$0.05$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Luminex Corp. (NASDAQ:LMNX)
Current Year EPS Consensus Estimate: $0.63 EPS
Next Year EPS Consensus Estimate: $0.63 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.13$0.14$0.14
Q2 20163$0.14$0.19$0.17
Q3 20163$0.04$0.19$0.12
Q4 20163$0.05$0.18$0.13
Q1 20171$0.06$0.06$0.06
Q2 20171$0.09$0.09$0.09
Q3 20171$0.07$0.07$0.07
Q4 20171$0.10$0.10$0.10
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Luminex Corp. (NASDAQ:LMNX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Luminex Corp. (NASDAQ:LMNX)
Insider Ownership Percentage: 6.90%
Institutional Ownership Percentage: 79.85%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/4/2016G Walter Loewenbaum IIDirectorSell41,056$20.53$842,879.68View SEC Filing  
12/31/2015G Walter Loewenbaum IIDirectorSell18,944$21.65$410,137.60View SEC Filing  
12/16/2015Russell W. BradleyCMOSell6,514$22.75$148,193.50View SEC Filing  
5/28/2015Nachum ShamirCEOBuy6,000$16.73$100,380.00View SEC Filing  
5/27/2015G Walter Loewenbaum IIDirectorBuy38,966$16.71$651,121.86View SEC Filing  
2/5/2015Fred C Goad JrDirectorSell25,000$15.46$386,500.00View SEC Filing  
10/8/2014Russell W BradleySVPSell5,000$20.50$102,500.00View SEC Filing  
5/15/2014Patrick BalthropCEOSell70,000$17.69$1,238,300.00View SEC Filing  
5/12/2014Kevin McnamaraDirectorSell5,000$17.95$89,750.00View SEC Filing  
5/9/2014Jim KeverDirectorSell5,000$17.52$87,600.00View SEC Filing  
5/7/2014Patrick BalthropCEOSell32,575$17.63$574,297.25View SEC Filing  
5/6/2014Patrick BalthropCEOSell60,000$18.28$1,096,800.00View SEC Filing  
5/2/2014Fred Goad, Jr.DirectorSell50,000$18.86$943,000.00View SEC Filing  
5/2/2014Patrick BalthropCEOSell55,000$19.05$1,047,750.00View SEC Filing  
5/1/2014David ReiterSVPSell15,000$19.09$286,350.00View SEC Filing  
5/1/2014Harriss CurrieCFOSell11,000$19.08$209,880.00View SEC Filing  
9/23/2013Harriss CurrieCFOSell30,000$19.88$596,400.00View SEC Filing  
9/17/2013Harriss CurrieCFOSell30,000$19.87$596,100.00View SEC Filing  
9/13/2013Michael PintekSVPSell3,000$20.00$60,000.00View SEC Filing  
8/30/2013G Walter Loewenbaum IIDirectorBuy6,034$20.62$124,421.08View SEC Filing  
8/28/2013G Walter Loewenbaum IIDirectorBuy20,000$20.76$415,200.00View SEC Filing  
8/16/2013Timothy DehneVPSell32,297$20.66$667,256.02View SEC Filing  
8/15/2013G Walter Loewenbaum IIDirectorBuy10,000$20.82$208,200.00View SEC Filing  
8/14/2013Timothy DehneVPSell1,793$21.21$38,029.53View SEC Filing  
8/9/2013G Walter Loewenbaum IIDirectorBuy4,600$21.17$97,382.00View SEC Filing  
8/2/2013G Walter Loewenbaum IIDirectorBuy27,000$20.01$540,270.00View SEC Filing  
8/2/2013Patrick J BalthropCEOSell68,048$20.01$1,361,640.48View SEC Filing  
8/1/2013David S ReiterSVPSell15,000$20.00$300,000.00View SEC Filing  
8/1/2013Thomas W EricksonDirectorSell20,000$20.00$400,000.00View SEC Filing  
5/24/2013Fred C Goad JrDirectorBuy11,250$18.25$205,312.50View SEC Filing  
5/17/2013G Walter Loewenbaum IIDirectorBuy13,000$18.37$238,810.00View SEC Filing  
5/16/2013Fred C Goad JrDirectorBuy8,000$18.18$145,440.00View SEC Filing  
5/15/2013G Walter Loewenbaum IIDirectorBuy39,500$18.32$723,640.00View SEC Filing  
5/10/2013David S ReiterSVPSell10,000$18.26$182,600.00View SEC Filing  
5/10/2013G Walter Loewenbaum IIDirectorBuy19,000$18.13$344,470.00View SEC Filing  
5/9/2013G Walter Loewenbaum IIDirectorBuy28,300$17.21$487,043.00View SEC Filing  
5/7/2013G Walter Loewenbaum IIDirectorBuy64,935$17.17$1,114,933.95View SEC Filing  
5/3/2013G Walter Loewenbaum IIDirectorBuy24,765$17.02$421,500.30View SEC Filing  
9/4/2012David S ReiterVPSell10,000$20.00$200,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Luminex Corp. (NASDAQ:LMNX)
DateHeadline
capitalcube.com logoLuminex Corp. – Value Analysis (NASDAQ:LMNX) : September 19, 2016 (NASDAQ:LMNX)
www.capitalcube.com - September 19 at 5:56 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : September 16, 2016 (NASDAQ:LMNX)
www.capitalcube.com - September 16 at 11:19 AM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:LMNX)
biz.yahoo.com - September 9 at 10:42 AM
finance.yahoo.com logoLuminex Poised on Pipeline Strength, System Sales Upbeat (NASDAQ:LMNX)
finance.yahoo.com - August 30 at 9:15 AM
capitalcube.com logoETF’s with exposure to Luminex Corp. : August 26, 2016 (NASDAQ:LMNX)
www.capitalcube.com - August 26 at 5:46 PM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K/A, Financial Statements and Exhibits (NASDAQ:LMNX)
biz.yahoo.com - August 25 at 5:57 PM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : August 25, 2016 (NASDAQ:LMNX)
www.capitalcube.com - August 25 at 11:01 AM
finance.yahoo.com logoLuminex upgraded by JP Morgan (NASDAQ:LMNX)
finance.yahoo.com - August 18 at 6:00 PM
finance.yahoo.com logoLuminex (LMNX) Receives FDA Clearance for xMAP Assay (NASDAQ:LMNX)
finance.yahoo.com - August 15 at 6:09 PM
capitalcube.com logoETF’s with exposure to Luminex Corp. : August 15, 2016 (NASDAQ:LMNX)
www.capitalcube.com - August 15 at 6:09 PM
capitalcube.com logoLuminex Corp. :LMNX-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016 (NASDAQ:LMNX)
www.capitalcube.com - August 12 at 6:03 PM
investors.com logoAre You Watching Medpace's IPO? Don't Ignore Its Larger Rival (NASDAQ:LMNX)
www.investors.com - August 12 at 6:03 PM
bizjournals.com logoAUSTIN: Biotech firm joins fight against Zika (NASDAQ:LMNX)
www.bizjournals.com - August 11 at 6:18 PM
bizjournals.com logoBiotech firm joins fight against Zika (NASDAQ:LMNX)
www.bizjournals.com - August 10 at 8:56 AM
4-traders.com logoLuminex : Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus (NASDAQ:LMNX)
www.4-traders.com - August 9 at 9:00 AM
News IconLuminex gets FDA emergency approval for Zika test (NASDAQ:LMNX)
gsnmagazine.com - August 9 at 9:00 AM
prnewswire.com logoLuminex Corporation Receives FDA Emergency Use Authorization for Zika Virus Molecular Detection Assay (NASDAQ:LMNX)
www.prnewswire.com - August 9 at 9:00 AM
streetinsider.com logoLuminex Corp. (LMNX) Receives FDA EUA for Zika Virus Molecular Detection Assay (NASDAQ:LMNX)
www.streetinsider.com - August 9 at 9:00 AM
feeds.benzinga.com logoFTC Sends Warning To Online Sources Capitalizing Off Zika Fear With 'Protective' Products (NASDAQ:LMNX)
feeds.benzinga.com - August 8 at 11:51 AM
feeds.reuters.com logoBRIEF-Luminex receives FDA emergency use authorization (NASDAQ:LMNX)
feeds.reuters.com - August 8 at 9:24 AM
finance.yahoo.com logoLUMINEX CORP Financials (NASDAQ:LMNX)
finance.yahoo.com - August 4 at 6:18 PM
finance.yahoo.com logoLuminex (LMNX) Gets FDA Nod for Assays; Q2 Earnings Beat (NASDAQ:LMNX)
finance.yahoo.com - August 3 at 6:17 PM
finance.yahoo.com logoLuminex Corporation Receives FDA Clearance for New Molecular Test for Identification and Differentiation of Influenza A/B and Respiratory Syncytial Virus (NASDAQ:LMNX)
finance.yahoo.com - August 3 at 9:12 AM
publicnow.com logoLuminex Corporation Reports Second Quarter 2016 Results (NASDAQ:LMNX)
www.publicnow.com - August 3 at 9:12 AM
finance.yahoo.com logoEdited Transcript of LMNX earnings conference call or presentation 29-Jul-16 12:30pm GMT (NASDAQ:LMNX)
finance.yahoo.com - July 29 at 5:22 PM
biz.yahoo.com logoLUMINEX CORP Files SEC form 10-Q, Quarterly Report (NASDAQ:LMNX)
biz.yahoo.com - July 29 at 10:28 AM
4-traders.com logoLuminex : posts 2Q profit (NASDAQ:LMNX)
www.4-traders.com - July 29 at 8:56 AM
biz.yahoo.com logoLuminex Corp Earnings Call scheduled for 8:30 am ET today (NASDAQ:LMNX)
biz.yahoo.com - July 29 at 8:30 AM
sg.finance.yahoo.com logoLuminex posts 2Q profit (NASDAQ:LMNX)
sg.finance.yahoo.com - July 28 at 6:32 PM
4-traders.com logoLuminex : Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time (NASDAQ:LMNX)
www.4-traders.com - July 28 at 6:08 PM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:LMNX)
biz.yahoo.com - July 28 at 4:31 PM
biz.yahoo.com logoQ2 2016 Luminex Corp Earnings Release - After Market Close (NASDAQ:LMNX)
biz.yahoo.com - July 28 at 7:07 AM
fidaily.com logoStock is unchanged at $22.12 (LMNX) Luminex Corporation Second Quarter… (NASDAQ:LMNX)
www.fidaily.com - July 20 at 10:30 PM
finance.yahoo.com logo8:33 am Luminex alters 2Q16 conference call date/time to July 29 at 8:30 am ET from July 28 at 4:30 pm ET (NASDAQ:LMNX)
finance.yahoo.com - July 20 at 8:33 AM
finance.yahoo.com logoLuminex Corporation Second Quarter Earnings Release Scheduled for July 28; Revision to Conference Call Date/Time (NASDAQ:LMNX)
finance.yahoo.com - July 20 at 8:30 AM
equities.com logoLuminex Corporation (LMNX) is Trading Higher on Unusual Volume for July 12 (NASDAQ:LMNX)
www.equities.com - July 14 at 9:33 AM
publicnow.com logoLuminex Corporation Receives FDA Clearance and CE-IVD Mark for the ARIES M1 System (NASDAQ:LMNX)
www.publicnow.com - July 8 at 8:41 AM
finance.yahoo.com logoLuminex Corporation Second Quarter Earnings Release Scheduled for July 28, 2016 (NASDAQ:LMNX)
finance.yahoo.com - July 8 at 8:30 AM
finance.yahoo.com logoLuminex Gets FDA Approval And CE-IVD Mark For Its ARIES M1 System (NASDAQ:LMNX)
finance.yahoo.com - July 6 at 7:57 AM
finance.yahoo.com logoLuminex Closes Nanosphere Buyout, Maintains FY16 View (NASDAQ:LMNX)
finance.yahoo.com - July 4 at 10:07 AM
4-traders.com logoLuminex : To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:LMNX)
www.4-traders.com - July 2 at 8:49 AM
streetinsider.com logoForm SC TO-T/A NANOSPHERE INC Filed by: LUMINEX CORP (NASDAQ:LMNX)
www.streetinsider.com - July 2 at 8:49 AM
equities.com logoLuminex Corporation (LMNX) is Trading Higher on Unusual Volume for June 30 (NASDAQ:LMNX)
www.equities.com - July 2 at 8:49 AM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bullish Manner : LMNX-US : July 1, 2016 (NASDAQ:LMNX)
www.capitalcube.com - July 1 at 8:22 AM
biz.yahoo.com logoLUMINEX CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibit (NASDAQ:LMNX)
biz.yahoo.com - June 30 at 2:19 PM
publicnow.com logoLuminex Corporation To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:LMNX)
www.publicnow.com - June 30 at 9:21 AM
finance.yahoo.com logoLuminex Corporation Completes Acquisition of Nanosphere, Inc. (NASDAQ:LMNX)
finance.yahoo.com - June 30 at 8:55 AM
capitalcube.com logoLuminex Corp. – Value Analysis (NASDAQ:LMNX) : June 21, 2016 (NASDAQ:LMNX)
www.capitalcube.com - June 21 at 11:31 AM
capitalcube.com logoLuminex Corp. breached its 50 day moving average in a Bearish Manner : LMNX-US : June 20, 2016 (NASDAQ:LMNX)
www.capitalcube.com - June 20 at 8:30 AM
finance.yahoo.com logoIncreased Earnings Estimates Seen for Luminex (LMNX): Can It Move Higher? (NASDAQ:LMNX)
finance.yahoo.com - June 2 at 8:47 AM

Social

Luminex Corp. (NASDAQ:LMNX) Chart for Thursday, September, 29, 2016


Last Updated on 9/29/2016 by MarketBeat.com Staff